James' 'Tour of the TAP'

14th October 2020

Cure Leukaemia Chief Executive, James McLaughlin, will run over 100 miles in November and December to raise funds for the 12 UK blood cancer centres the charity supports. James, 46, will run the equivalent of four marathons in completing his ‘Tour of the TAP’ challenge which aims to raise funds for Cure Leukaemia in a year where the charity faces a £1,500,000 shortfall as a result of the COVID-19 pandemic.


 Click Here To Sponsor James 


TAP, which stands for the Trials Acceleration Programme, consists of a network of specialist research nurses based in 12 of the UK’s biggest cities and a facilitatory Hub at the Centre for Clinical Haematology (CCH) in Birmingham. TAP, which Cure Leukaemia made a 3-year £3,000,000 commitment to funding in January 2020, enables the accelerated setup and delivery of pioneering and potentially life-saving blood cancer clinical trials. The research nurses across the UK and the co-ordinating Hub allow these trials to run, giving patients from a catchment area of over 20 million people access to potentially life-saving treatments not currently available through standard care.

James will begin his challenge by running 14 kilometers from the CCH in Birmingham on Thursday 12th November with CEO of the Greater Birmingham Chambers of Commerce Paul Faulkner is set to join James virtually for his first leg in the Second City having also pledged £250 sponsorship from the Chamber to support his fundraising.

Speaking about the challenge James said:


The COVID-19 pandemic has decimated the fundraising plans of charities across the world with the cancellation of key events. Whilst this is clearly a challenging time for us all I wanted to do something positive to help blood cancer patients across the UK.


A person is diagnosed with blood cancer every 14 minutes in the UK so that is why I have decided to run 14km for patients at each of the 12 blood cancer locations we fund as part of the TAP.


“I’m very grateful for Paul’s support to join me for the start of the challenge which will begin at the Centre for Clinical Haematology in Birmingham. Whilst I won’t be able to run in each of the 12 cities, I hope that others will be able to join me by doing their own 14km runs or think of different ways to raise funds on those days.


Paul Faulkner, who is also a Trustee of Cure Leukaemia, said:


Cure Leukaemia’s ethos as a charity is positivity and, by taking on this challenge, James is highlighting exactly this by turning the most testing of years into a positive.


While we can’t take part in traditional mass participation marathons or half marathons at the moment, there is nothing stopping us from setting our own challenges. 14km will be the furthest I’ve ever run in one go as far as I can recall; but given the wider challenge that James is undertaking I’m all too happy to join him for the first 14km and sponsor the cause. I hope many others follow our lead across all 12 TAP centre locations.


James continued:

Patients are the driving force for everything we do at Cure Leukaemia and patients are battling this disease during a global pandemic. I will have all patients across the West Midlands in my mind throughout my Birmingham run and look forward to connecting with patients being treated at centres across the TAP in the coming weeks.


“I’ve run a marathon before but never 4 marathons in a short space of time so this will be a big challenge for me, and I hope people will either join me or help me raise funds during my ‘Tour of the TAP’.


James' Running Schedule

 Birmingham  Thursday 12 November
 Cardiff  Monday 16 November
 Belfast  Wednesday 18 November
 UCLH London  Saturday 21 November
 Nottingham  Monday 23 November
 Leeds  Thursday 26 November
 Christie Manchester  Monday 30 November
 Oxford  Thursday 3 December
 Southampton  Friday 4 December
 Glasgow  Monday 7 December
 Guy's & St Thomas' London  Wednesday 9 December
 Sheffield  Saturday 12 December


 Click Here To Sponsor James 

< Back to List

What we do

The Trials Acceleration Programme (TAP)

How funds raised for Cure Leukaemia help save lives

Cure Leukamia Pre footer image
"Cure Leukaemia’s funding of the UK Trials Acceleration Programme (TAP) is a game-changer and increases the access for blood cancer patients to potentially transformative new therapies."

Sir John Bell
"Cure Leukaemia’s funding of the UK Trials Acceleration Programme (TAP) is a game-changer and increases the access for blood cancer patients to potentially transformative new therapies."

Sir John Bell